Form 4: U.S. Physical Therapy Director Clayton Trier Reports Acquisition of Restricted Stock

Director Clayton Trier reports acquisition of 1,882 shares of restricted stock in U.S. Physical Therapy, Inc.

Summary

• Clayton Trier, a director of U.S. Physical Therapy Inc., filed a Form 4 indicating changes in beneficial ownership.
• On May 20, 2025, Trier acquired 1,882 shares of common stock.
• These shares were granted as restricted stock under the company's 2003 Stock Incentive Plan.
• The restrictions on the shares will lapse in three tranches: 941 shares on August 20, 2025, 470 shares on November 20, 2025, and 471 shares on March 6, 2026, contingent on Trier remaining a director on those dates.
• Following the transaction, Trier directly owns 8,306 shares of U.S. Physical Therapy Inc.

Sentiment

Score: 5

Explanation: Neutral sentiment as it is a standard regulatory filing related to stock ownership.

Positives

• The acquisition of restricted stock aligns the director's interests with those of the company and its shareholders.

Future Outlook

The vesting of the restricted stock is contingent on Clayton Trier remaining a director of the company.

Industry Context

Form 4 filings are routine disclosures for corporate insiders and provide transparency regarding their transactions in the company's stock.

Stakeholder Impact

• The acquisition of restricted stock aligns the director's interests with those of the shareholders.

Key Dates

Keywords

Form 4, beneficial ownership, restricted stock, director, USPH, U.S. Physical Therapy Inc., Clayton Trier